Pharma Mar S.A. | |
Stock Exchange | Other OTC |
EPS |
$0.13 |
Market Cap |
$473.44 M |
Shares Outstanding |
222.2 M |
Public Float |
- |
Pharma Mar S.A. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
222.2 M |
Public Float |
- |
Address |
Avenida de los Reyes, 1 Colmenar Viejo Madrid 28770 Spain |
Employees | - |
Website | http://www.pharmamar.es |
Updated | 07/08/2019 |
Pharma Mar SA is a biopharmaceutical holding company, which engages in discovery and development of innovative marine-derived anticancer drugs. It operates through the following segments: Oncology, Diagnostics, RNAi, and Consumer Chemicals. The Oncology segment encompasses the Group undertakings whose object is to research, develop and market anti-tumour drugs. |